HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neil Stahl Selected Research

Methotrexate (Mexate)

6/2015Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.
9/2014Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Neil Stahl Research Topics

Disease

11Asthma (Bronchial Asthma)
01/2021 - 06/2013
10COVID-19
10/2022 - 01/2020
10Infections
01/2022 - 03/2012
10Atopic Dermatitis (Atopic Eczema)
01/2020 - 07/2014
8Injection Site Reaction
01/2020 - 08/2008
8Inflammation (Inflammations)
01/2020 - 06/2013
5Eczema
01/2020 - 07/2014
5Macular Degeneration (Age-Related Maculopathy)
01/2016 - 06/2011
4Nasopharyngitis
02/2016 - 06/2013
3Sinusitis
01/2020 - 01/2016
3Conjunctivitis
01/2020 - 12/2016
3Nasal Polyps (Nasal Polyp)
11/2019 - 01/2016
3Headache (Headaches)
02/2016 - 06/2013
3Rheumatoid Arthritis
06/2015 - 12/2009
2Asymptomatic Infections
09/2021 - 01/2021
2Pain (Aches)
01/2021 - 11/2019
2Eosinophilia
01/2018 - 01/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2017 - 12/2015
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 12/2015
2Pruritus (Itching)
12/2016 - 07/2014
2Neoplasms (Cancer)
01/2016 - 11/2007
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
12/2015 - 03/2012
2Macular Edema
10/2015 - 11/2014
2Neutropenia
06/2015 - 09/2014
2Gout
03/2012 - 12/2009
2Cryopyrin-Associated Periodic Syndromes
12/2009 - 08/2008
1Pneumonia (Pneumonitis)
01/2022
1Low Back Pain (Lumbago)
01/2021
1Hypersensitivity (Allergy)
01/2021
1Allergic Rhinitis
01/2021
1Eosinophilic Esophagitis
01/2020
1Communicable Diseases (Infectious Diseases)
01/2020
1Body Weight (Weight, Body)
01/2020
1Deglutition Disorders (Dysphagia)
01/2020
1Airway Remodeling
12/2019
1Polyps
11/2019
1Rhinosinusitis
11/2019
1Joint Diseases (Joint Disease)
11/2019
1Osteoarthritis
11/2019
1Ebola Hemorrhagic Fever
11/2018
1Respiratory Tract Infections (Respiratory Tract Infection)
07/2016
1Kidney Neoplasms (Kidney Cancer)
01/2016
1Vascular Diseases (Vascular Disease)
01/2016

Drug/Important Bio-Agent (IBA)

20Monoclonal AntibodiesIBA
10/2022 - 03/2012
14dupilumabIBA
01/2020 - 06/2013
9casirivimab and imdevimab drug combinationIBA
10/2022 - 11/2020
8Interleukin-13IBA
01/2020 - 07/2014
8afliberceptIBA
01/2016 - 11/2007
7Interleukin-4 (Interleukin 4)IBA
01/2020 - 07/2014
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 11/2007
4AntibodiesIBA
01/2022 - 07/2015
4Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2015
4Neutralizing AntibodiesIBA
01/2021 - 07/2015
4CytokinesIBA
01/2020 - 01/2016
4Pharmaceutical PreparationsIBA
11/2019 - 06/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2019 - 02/2016
3AllergensIBA
01/2021 - 01/2020
3InterleukinsIBA
11/2019 - 01/2016
3GlucocorticoidsIBA
01/2018 - 06/2013
3sarilumabIBA
06/2015 - 09/2014
3Biomarkers (Surrogate Marker)IBA
07/2014 - 11/2007
3rilonaceptFDA Link
03/2012 - 08/2008
3Interleukin-1 (Interleukin 1)IBA
03/2012 - 08/2008
2fasinumabIBA
01/2021 - 11/2019
2Immunoglobulin A (IgA)IBA
01/2020 - 10/2017
2LipidsIBA
01/2017 - 09/2014
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
12/2016 - 06/2013
2Ranibizumab (Lucentis)FDA Link
01/2016 - 12/2012
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
06/2015 - 09/2014
2Methotrexate (Mexate)FDA LinkGeneric
06/2015 - 09/2014
1COVID-19 VaccinesIBA
10/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoglobulin IsotypesIBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
09/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021
1Opioid Analgesics (Opioids)IBA
01/2021
1ChemokinesIBA
01/2020
1Interleukin-33IBA
12/2019
1Analgesics (Analgesic Drugs)IBA
11/2019
1Prostaglandins AIBA
11/2019
1Nerve Growth Factor (NGF)IBA
11/2019
1Bronchodilator Agents (Bronchodilators)IBA
01/2018
1PlacebosIBA
01/2018
1Mometasone Furoate (Nasonex)FDA LinkGeneric
02/2016
1Nasal SpraysIBA
02/2016
1Immunoglobulin E (IgE)IBA
01/2016
1Retinaldehyde (Retinal)IBA
01/2016
1Bevacizumab (Avastin)FDA Link
01/2016
1Interleukin-5 (Interleukin 5)IBA
01/2016
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2016
1pegaptanib (Macugen)FDA Link
01/2016
1alirocumabIBA
12/2015
1oxidized low density lipoproteinIBA
12/2015

Therapy/Procedure

8Therapeutics
11/2020 - 03/2012
2Lasers (Laser)
10/2015 - 11/2014
1Subcutaneous Injections
01/2021
1Intranasal Administration
01/2020
1Aftercare (After-Treatment)
01/2016